These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38839265)

  • 1. Safety update: psychiatric and sexual adverse effects with finasteride.
    Drug Ther Bull; 2024 Jul; 62(7):101. PubMed ID: 38839265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Finasteride adverse effects: An update].
    Carreño-Orellana N; Moll-Manzur C; Carrasco-Zuber JE; Álvarez-Véliz S; Berroeta-Mauriziano D; Porras-Kusmanic N
    Rev Med Chil; 2016 Dec; 144(12):1584-1590. PubMed ID: 28393993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial.
    Kaplan SA; Lee JY; Meehan AG; Kusek JW
    J Urol; 2016 Jun; 195(6):1825-9. PubMed ID: 26678956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [How effective is finasteride?].
    Krome S
    Dtsch Med Wochenschr; 2011 Feb; 136(8):354. PubMed ID: 21348003
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
    Kaplan SA
    J Urol; 2014 Mar; 191(3):752. PubMed ID: 24522062
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature.
    Busetto GM; Del Giudice F; D'Agostino D; Romagnoli D; Minervini A; Rocco B; Antonelli A; Celia A; Schiavina R; Cindolo L; Chung BI; Kim JH; Maggi M; Sciarra A; De Berardinis E; Porreca A
    Arch Ital Urol Androl; 2020 Jan; 91(4):205-210. PubMed ID: 31937082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 8. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitors.
    Harrell MB; Ho K; Te AE; Kaplan SA; Chughtai B
    World J Urol; 2021 Apr; 39(4):1233-1239. PubMed ID: 32596745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia.
    Alcántara Montero A; Müller-Arteaga C
    Actas Urol Esp (Engl Ed); 2019; 43(1):52-53. PubMed ID: 30032935
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland.
    Ząbkowski T
    Pharmacol Rep; 2014 Aug; 66(4):565-9. PubMed ID: 24948055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-finasteride syndrome.
    Gray SL; Semla TP
    BMJ; 2019 Aug; 366():l5047. PubMed ID: 31399423
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of 5α-Reductase Inhibitor Use on Mortality From Prostate Cancer.
    Figg WD; Thompson IM
    JAMA Oncol; 2015 Jun; 1(3):321-2. PubMed ID: 26181178
    [No Abstract]   [Full Text] [Related]  

  • 14. On call. I have read several news reports that claim finasteride, which I take for my prostate problem, can cause permanent impotence. Should I be concerned?
    Kormos W
    Harv Mens Health Watch; 2013 Jan; 17(6):2. PubMed ID: 23807950
    [No Abstract]   [Full Text] [Related]  

  • 15. 5 alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia.
    Stoner E
    Recent Prog Horm Res; 1994; 49():285-92. PubMed ID: 7511828
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate, baldness drugs linked to sexual dysfunction.
    Kuehn BM
    JAMA; 2012 May; 307(18):1903. PubMed ID: 22570451
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-finasteride syndrome.
    Pereira AFJR; Coelho TOA
    An Bras Dermatol; 2020; 95(3):271-277. PubMed ID: 32317131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs.
    Pirozzi Farina F; Pischedda A
    Arch Ital Urol Androl; 2016 Jan; 87(4):312-6. PubMed ID: 26766804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Depression Associated With Finasteride Treatment.
    Pompili M; Magistri C; Maddalena S; Mellini C; Persechino S; Baldessarini RJ
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):304-309. PubMed ID: 33814544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation.
    Cecchin E; De Mattia E; Mazzon G; Cauci S; Trombetta C; Toffoli G
    Int J Biol Markers; 2014 Dec; 29(4):e310-6. PubMed ID: 24855036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.